REVOLUTION MEDICINES INC stock forecast: up to 22.65 USD RVMD stock price prognosis


Forecast for Fri 19 May 2023 price 23.43

REVOLUTION MEDICINES INC stock price forecast for further price development up to 4.03% (time horizon: 1 day) and price target of 22.65 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) REVOLUTION MEDICINES INC share price prediction for 2023-05-19 with daily closed price projections

Key Facts

Symbol RVMD 

Currency USD

Category Biological Products (No Diagnostic Substances)

Forecast price change %

News sentiment (0.90)

News <--> Close correlation for next day influence (-0.16)

Finance numbers

Revenue 41,568,000.0

Earnings per share -1.80

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

We plan to study this candidate first as a monotherapy. po = per os (oral administration) and qd = daily. In (upper right) each animal is represented as a separate bar. Numerous unmet needs in RAS-addicted cancers may be served by a RASMULTI inhibitor. RMC-6236 caused regressions in preclinical xenograft model of tumors harboring KRASG12V . Each animal is represented as a separate bar. Demographic and baseline characteristics information is shown in Table 1. Abbreviations: SMQ, Standardized MedDRA Query; CMQ, Customized MedDRA Query. * Includes hemoglobin count decrease. ** A second patient had pneumonia which is not an expected event for RMC-4630. For all patients with KRASMUTANT NSCLC, DCR was 17/29 (59%) (Figure 12). Best change in tumor burden from baseline in KRASMUTANT non-small cell lung cancer. We plan to provide RMC-4630 to support this investigator-sponsored study. Orphan drug designation must be requested before submitting an NDA. These developments may delay our clinical trial timelines. Since inception, we have incurred significant net losses. There is a high failure rate for drugs proceeding through clinical trials. In many countries, the pricing review period begins after marketing approval is granted. The applicable period is seven years in the United States and ten years in Europe. Penalties for violations of these laws vary and may be significant. In addition, quality issues may arise during scale-up activities and at any other time. Moreover, the length of the extension could be less than we request. We may not be able to protect our intellectual property rights throughout the world. This could limit our potential revenue opportunities. In certain circumstances, we rely on our licensors and collaborators to pay these fees. We are highly dependent on members of our executive team. We currently do not have a marketing or sales organization. An active and liquid market for our common stock may not be sustained. We currently intend to invest our future earnings, if any, to fund our growth.

Summerized Form 10-K with GPT-2
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 39.06/100
    • Good financial position.
    • Historical view, profit is growing.
    • Company revenue is not growing faster compared with the industry.


CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1800668 Anders Jack 2023-03-17 SALE Accept Accept Accept Accept
1294192 Horn Margaret A 2023-03-17 SALE Accept Accept Accept Accept
1462808 Kelsey Stephen Michael 2023-03-17 SALE Accept Accept Accept Accept
1776412 Schroeder Thilo 2023-03-10 BUY Reject Reject Reject Reject
1849181 Wang Xiaolin 2023-03-17 SALE Accept Accept Accept Accept

Bollinger Bollinger Bands for REVOLUTION MEDICINES INC can provide the information where the market is moving based on price information.

REVOLUTION MEDICINES INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns REVOLUTION MEDICINES INC.

On-Balance Volume information for REVOLUTION MEDICINES INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for REVOLUTION MEDICINES INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for REVOLUTION MEDICINES INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for REVOLUTION MEDICINES INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for REVOLUTION MEDICINES INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for REVOLUTION MEDICINES INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for REVOLUTION MEDICINES INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

52W High 52W Low Market Cap

Similar shares



Figure below show the stock predictions.
Date Closing price Prediction was updated
2023-04-27 22.65 2023-03-25 03:16
2023-04-28 22.73 2023-03-25 03:16
2023-05-01 22.77 2023-03-25 03:16
2023-05-02 22.82 2023-03-25 03:16
2023-05-03 22.86 2023-03-25 03:16
2023-05-04 22.92 2023-03-25 03:16
2023-05-05 22.96 2023-03-25 03:16
2023-05-11 23.15 2023-03-25 03:16
2023-05-12 23.20 2023-03-25 03:16
2023-05-08 23.01 2023-03-25 03:16
2023-05-09 23.06 2023-03-25 03:16
2023-05-10 23.10 2023-03-25 03:16
2023-05-15 23.24 2023-03-25 03:16
2023-05-16 23.29 2023-03-25 03:16
2023-05-17 23.34 2023-03-25 03:16
2023-05-18 23.37 2023-03-25 03:16
2023-05-19 23.43 2023-03-25 03:16
2023-04-07 21.80 2023-03-25 03:16
2023-03-27 20.80 2023-03-25 03:16
2023-03-28 21.12 2023-03-25 03:16
2023-03-29 20.99 2023-03-25 03:16
2023-03-30 21.10 2023-03-25 03:16
2023-03-31 21.50 2023-03-25 03:16
2023-04-03 21.27 2023-03-25 03:16
2023-04-04 21.49 2023-03-25 03:16
2023-04-05 21.53 2023-03-25 03:16
2023-04-06 21.63 2023-03-25 03:16
2023-04-10 21.83 2023-03-25 03:16
2023-04-11 21.88 2023-03-25 03:16
2023-04-12 21.96 2023-03-25 03:16
2023-04-13 22.12 2023-03-25 03:16
2023-04-14 22.14 2023-03-25 03:16
2023-04-17 22.21 2023-03-25 03:16
2023-04-18 22.32 2023-03-25 03:16
2023-04-19 22.35 2023-03-25 03:16
2023-04-20 22.39 2023-03-25 03:16
2023-04-21 22.50 2023-03-25 03:16
2023-04-24 22.49 2023-03-25 03:16
2023-04-25 22.58 2023-03-25 03:16
2023-04-26 22.63 2023-03-25 03:16

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.